{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:42:30Z","timestamp":1788378150030,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.otc.2017.09.017","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T23:18:22Z","timestamp":1512515902000},"page":"237-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Hereditary Hemorrhagic Telangiectasia"],"prefix":"10.1016","volume":"51","author":[{"given":"Thomas","family":"K\u00fchnel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Wirsching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Wohlgemuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Evert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Vielsmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.otc.2017.09.017_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/lary.24303","article-title":"A\u00a0modified technique for septodermoplasty in hereditary hemorrhagic telangiectasia","volume":"124","author":"Rimmer","year":"2014","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.otc.2017.09.017_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2009.069013","article-title":"International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia","volume":"48","author":"Faughnan","year":"2011","journal-title":"J\u00a0Med Genet"},{"issue":"7","key":"10.1016\/j.otc.2017.09.017_bib3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ejhg.2009.35","article-title":"Hereditary haemorrhagic telangiectasia: a clinical and scientific review","volume":"17","author":"Govani","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.otc.2017.09.017_bib4","first-page":"s2","article-title":"Trauma can induce teleangiectases in patients with hereditary hemrhagic teleangiectasia","volume":"3","author":"Geisthoff","year":"2011","journal-title":"Hematol Rep"},{"issue":"8","key":"10.1016\/j.otc.2017.09.017_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/thx.2009.129932","article-title":"SMAD4 mutation and the combined syndrome of juvenile polyposis syndrome and hereditary haemorrhagic telangiectasia","volume":"65","author":"Iyer","year":"2010","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.otc.2017.09.017_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4193\/Rhin12.043","article-title":"Silent threat? A retrospective study of screening practices for pulmonary arteriovenous malformations in patients with hereditary haemorrhagic telangiectasia","volume":"50","author":"Verkerk","year":"2012","journal-title":"Rhinology"},{"issue":"1","key":"10.1016\/j.otc.2017.09.017_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2796.1999.00398.x","article-title":"Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients","volume":"245","author":"Kjeldsen","year":"1999","journal-title":"J\u00a0Intern Med"},{"issue":"3","key":"10.1016\/j.otc.2017.09.017_bib8","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ijcard.2014.08.016","article-title":"High prevalence of arterial aneurysms in hereditary hemorrhagic telangiectasia","volume":"176","author":"Moulinet","year":"2014","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.otc.2017.09.017_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM200108023450503","article-title":"Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia","volume":"345","author":"Trembath","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.otc.2017.09.017_bib10","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.0000000000001538","article-title":"Complications and mortality in hereditary hemorrhagic telangiectasia: a population-based study","volume":"84","author":"Donaldson","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.otc.2017.09.017_bib11","first-page":"1322","article-title":"\u00c8pistaxis r\u00e9p\u00e9t\u00e9es chez un sujet porteur de petits angiomes cutan\u00e9s et muque","volume":"135","author":"Rendu","year":"1896","journal-title":"Gazettes des Hopitaux"},{"key":"10.1016\/j.otc.2017.09.017_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13023-016-0427-x","article-title":"Life expectancy of parents with hereditary haemorrhagic telangiectasia","volume":"11","author":"de Gussem","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.otc.2017.09.017_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1158\/1055-9965.EPI-13-0665","article-title":"Improved survival outcomes in cancer patients with hereditary hemorrhagic telangiectasia","volume":"23","author":"Duarte","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.otc.2017.09.017_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00432-016-2272-7","article-title":"Cancer incidence in patients with hereditary hemorrhagic telangiectasia","volume":"143","author":"Duarte","year":"2017","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.otc.2017.09.017_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/194589240501900112","article-title":"The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia","volume":"19","author":"Lennox","year":"2005","journal-title":"Am J Rhinol"},{"issue":"5","key":"10.1016\/j.otc.2017.09.017_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.otohns.2006.12.019","article-title":"Health-related quality of life in hereditary hemorrhagic telangiectasia","volume":"136","author":"Geisthoff","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.otc.2017.09.017_bib17","first-page":"26ff","article-title":"Morbus osler - erkrankung","author":"Kuehnel","year":"2014","journal-title":"Forum Sanitas"},{"key":"10.1016\/j.otc.2017.09.017_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13023-014-0115-7","article-title":"Targeting under-diagnosis in hereditary hemorrhagic telangiectasia: a model approach for rare diseases?","volume":"9","author":"Latino","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.otc.2017.09.017_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/thoraxjnl-2013-203720","article-title":"The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study","volume":"69","author":"Donaldson","year":"2014","journal-title":"Thorax"},{"issue":"9412","key":"10.1016\/j.otc.2017.09.017_bib20","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","article-title":"A\u00a0combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4)","volume":"363","author":"Gallione","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.otc.2017.09.017_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.otc.2017.09.017_bib22","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.1542\/peds.109.1.e12","article-title":"Intracranial hemorrhage in infants and children with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)","volume":"109","author":"Morgan","year":"2002","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.otc.2017.09.017_bib23","first-page":"879","article-title":"Medical complications of pregnancy in hereditary haemorrhagic telangiectasia","volume":"88","author":"Shovlin","year":"1995","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.otc.2017.09.017_bib24","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/ajmg.a.35309","article-title":"Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: a population based study","volume":"158A","author":"Geirdal","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"927","key":"10.1016\/j.otc.2017.09.017_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/pmj.79.927.18","article-title":"Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century","volume":"79","author":"Begbie","year":"2003","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.otc.2017.09.017_bib26","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lary.20818","article-title":"An epistaxis severity score for hereditary hemorrhagic telangiectasia","volume":"120","author":"Hoag","year":"2010","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.otc.2017.09.017_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2500\/105065899782102890","article-title":"A\u00a0treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia","volume":"13","author":"Lund","year":"1999","journal-title":"Am J Rhinol"},{"issue":"2","key":"10.1016\/j.otc.2017.09.017_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.21053\/ceo.2016.00318","article-title":"Update on clinical strategies in hereditary hemorrhagic telangiectasia from an ENT point of view","volume":"10","author":"Wirsching","year":"2017","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"3","key":"10.1016\/j.otc.2017.09.017_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.thromres.2014.06.012","article-title":"Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study","volume":"134","author":"Geisthoff","year":"2014","journal-title":"Thromb Res"},{"issue":"9","key":"10.1016\/j.otc.2017.09.017_bib30","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jth.12654","article-title":"Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease","volume":"12","author":"Gaillard","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"10.1016\/j.otc.2017.09.017_bib31","first-page":"85","article-title":"The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study","volume":"47","author":"de Gussem","year":"2009","journal-title":"Rhinology"},{"issue":"5","key":"10.1016\/j.otc.2017.09.017_bib32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/194589240501900515","article-title":"Clinical strategy in hereditary hemorrhagic telangiectasia","volume":"19","author":"K\u00fchnel","year":"2005","journal-title":"Am J Rhinol"},{"issue":"2","key":"10.1016\/j.otc.2017.09.017_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/00016489.2012.718097","article-title":"Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds","volume":"133","author":"Pagella","year":"2013","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"10.1016\/j.otc.2017.09.017_bib34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.otc.2016.02.010","article-title":"Treatment of hereditary hemorrhagic telangiectasia-related epistaxis","volume":"49","author":"Sautter","year":"2016","journal-title":"Otolaryngol Clin North Am"},{"issue":"6","key":"10.1016\/j.otc.2017.09.017_bib35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.otohns.2008.01.005","article-title":"Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia","volume":"138","author":"Levine","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.otc.2017.09.017_bib36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.mlg.0000154754.39797.43","article-title":"Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia","volume":"115","author":"Fiorella","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2017.09.017_bib37","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1001\/jama.1960.63030150005020","article-title":"Hereditary hemorrhagic telangiectasia. control of nosebleeds by septal dermoplasty","volume":"174","author":"Saunders","year":"1960","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.otc.2017.09.017_bib38","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1055\/s-2007-997466","article-title":"Critical evaluation of vascular embolization in patients with Rendu-Osler disease","volume":"76","author":"Fischer","year":"1997","journal-title":"Laryngorhinootologie"},{"issue":"1","key":"10.1016\/j.otc.2017.09.017_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/019459989411100110","article-title":"Angiographic embolization for the treatment of epistaxis: a review of 108 cases","volume":"111","author":"Elden","year":"1994","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"111","key":"10.1016\/j.otc.2017.09.017_bib40","first-page":"30","article-title":"Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic teleangiectasia","author":"Lund","year":"1996","journal-title":"J\u00a0Laryngol Otol"},{"issue":"4","key":"10.1016\/j.otc.2017.09.017_bib41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10456-015-9482-5","article-title":"Executive summary of the 11th HHT international scientific conference","volume":"18","author":"Arthur","year":"2015","journal-title":"Angiogenesis"},{"issue":"4","key":"10.1016\/j.otc.2017.09.017_bib42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1378\/chest.09-1849","article-title":"Real prevalence of pulmonary right-to-left shunt according to genotype in patients with hereditary hemorrhagic telangiectasia: a transthoracic contrast echocardiography study","volume":"138","author":"van Gent","year":"2010","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.otc.2017.09.017_bib43","doi-asserted-by":"crossref","first-page":"e90937","DOI":"10.1371\/journal.pone.0090937","article-title":"Impact of pulmonary arteriovenous malformations on respiratory-related quality of life in patients with hereditary haemorrhagic telangiectasia","volume":"9","author":"Blivet","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.otc.2017.09.017_bib44","doi-asserted-by":"crossref","first-page":"e88812","DOI":"10.1371\/journal.pone.0088812","article-title":"Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets","volume":"9","author":"Shovlin","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.otc.2017.09.017_bib45","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1183\/09031936.00061308","article-title":"The pulmonary vascular complications of hereditary haemorrhagic telangiectasia","volume":"33","author":"Faughnan","year":"2009","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.otc.2017.09.017_bib46","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s00270-016-1357-7","article-title":"Amplatzer vascular plugs versus coils for embolization of pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia","volume":"39","author":"Tau","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1\u20132","key":"10.1016\/j.otc.2017.09.017_bib47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000081053","article-title":"Brain abscess: a need to screen for pulmonary arteriovenous malformations","volume":"24","author":"Gallitelli","year":"2005","journal-title":"Neuroepidemiology"},{"issue":"8","key":"10.1016\/j.otc.2017.09.017_bib48","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/thx.54.8.714","article-title":"Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms","volume":"54","author":"Shovlin","year":"1999","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.otc.2017.09.017_bib49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4330\/wjc.v7.i5.230","article-title":"Pulmonary hypertension in hereditary haemorrhagic telangiectasia","volume":"7","author":"Vorselaars","year":"2015","journal-title":"World J Cardiol"},{"issue":"11","key":"10.1016\/j.otc.2017.09.017_bib50","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00330-004-2455-5","article-title":"Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations","volume":"14","author":"Chavan","year":"2004","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.otc.2017.09.017_bib51","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00330-012-2694-9","article-title":"Complications and clinical outcome of hepatic artery embolisation in patients with hereditary haemorrhagic telangiectasia","volume":"23","author":"Chavan","year":"2013","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.otc.2017.09.017_bib52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1024\/0301-1526\/a000253","article-title":"Systemic therapy with bevacizumab in patients with hereditary hemorrhagic telangiectasia (HHT)","volume":"42","author":"Chavan","year":"2013","journal-title":"VASA Z Gefasskrankheiten"},{"issue":"9","key":"10.1016\/j.otc.2017.09.017_bib53","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","volume":"307","author":"Dupuis-Girod","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.otc.2017.09.017_bib54","first-page":"302","article-title":"Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis","volume":"127","author":"Brinjikji","year":"2017","journal-title":"J\u00a0Neurosurg"},{"issue":"12","key":"10.1016\/j.otc.2017.09.017_bib55","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s00234-005-1448-7","article-title":"Hereditary hemorrhagic telangiectasia in children: endovascular treatment of neurovascular malformations: results in 31 patients","volume":"47","author":"Krings","year":"2005","journal-title":"Neuroradiology"},{"issue":"3","key":"10.1016\/j.otc.2017.09.017_bib56","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/AOG.0000000000000120","article-title":"Outcomes of pregnancy in women with hereditary hemorrhagic telangiectasia","volume":"123","author":"de Gussem","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.otc.2017.09.017_bib57","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/1591019915623560","article-title":"Spinal arteriovenous fistulae in patients with hereditary hemorrhagic telangiectasia: a case report and systematic review of the literature","volume":"22","author":"Brinjikji","year":"2016","journal-title":"Interv Neuroradiol"},{"issue":"9","key":"10.1016\/j.otc.2017.09.017_bib58","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1471-0528.2008.01786.x","article-title":"Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): suggested approach for obstetric services","volume":"115","author":"Shovlin","year":"2008","journal-title":"BJOG"},{"issue":"11","key":"10.1016\/j.otc.2017.09.017_bib59","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s00234-003-1044-7","article-title":"Giant spinal perimedullary fistula in hereditary haemorrhagic telangiectasia: diagnosis, endovascular treatment and review of the literature","volume":"45","author":"Mont'Alverne","year":"2003","journal-title":"Neuroradiology"},{"issue":"5","key":"10.1016\/j.otc.2017.09.017_bib60","first-page":"1031","article-title":"Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism","volume":"98","author":"Shovlin","year":"2007","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.otc.2017.09.017_bib61","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2174\/138161206776361336","article-title":"Patients with hereditary hemorrhagic telangectasia (HHT) exhibit a deficit of polymorphonuclear cell and monocyte oxidative burst and phagocytosis: a possible correlation with altered adaptive immune responsiveness in HHT","volume":"12","author":"Cirulli","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"6","key":"10.1016\/j.otc.2017.09.017_bib62","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1086\/511645","article-title":"Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases: an underestimated association","volume":"44","author":"Dupuis-Girod","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.otc.2017.09.017_bib63","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/joim.12098","article-title":"Immunological abnormalities associated with hereditary haemorrhagic telangiectasia","volume":"274","author":"Guilhem","year":"2013","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.otc.2017.09.017_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1750-1172-8-195","article-title":"Specific cancer rates may differ in patients with hereditary haemorrhagic telangiectasia compared to controls","volume":"8","author":"Hosman","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.otc.2017.09.017_bib65","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00417-006-0520-2","article-title":"Prevalence of ocular manifestations in hereditary hemorrhagic telangiectasia","volume":"245","author":"Geisthoff","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.otc.2017.09.017_bib66","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1468-2982.2008.01703.x","article-title":"An association of migraine with hereditary haemorrhagic telangiectasia independently of pulmonary right-to-left shunts","volume":"29","author":"Marziniak","year":"2009","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.otc.2017.09.017_bib67","first-page":"106","article-title":"Asymptomatic microhematuria: an indication of hereditary hemorrhagic telangiectasia?","volume":"173","author":"Di Gennaro","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"12","key":"10.1016\/j.otc.2017.09.017_bib68","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4240\/wjgs.v8.i12.792","article-title":"Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia","volume":"8","author":"Ou","year":"2016","journal-title":"World J Gastrointest Surg"},{"issue":"11","key":"10.1016\/j.otc.2017.09.017_bib69","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/alr.21587","article-title":"Intravenous bevacizumab for complications of hereditary hemorrhagic telangiectasia: a review of the literature","volume":"5","author":"Arizmendez","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"10.1016\/j.otc.2017.09.017_bib70","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5045\/br.2014.49.3.192","article-title":"Hereditary hemorrhagic telangiectasia treated with low dose intravenous bevacizumab","volume":"49","author":"Wee","year":"2014","journal-title":"Blood Res"},{"issue":"6","key":"10.1016\/j.otc.2017.09.017_bib71","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/hed.23655","article-title":"Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial","volume":"37","author":"Riss","year":"2015","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.otc.2017.09.017_bib72","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00405-011-1721-9","article-title":"A\u00a0retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia","volume":"269","author":"Rohrmeier","year":"2012","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"10.1016\/j.otc.2017.09.017_bib73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1160\/TH11-11-0809","article-title":"Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia","volume":"108","author":"Albinana","year":"2012","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.otc.2017.09.017_bib74","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.anl.2015.12.001","article-title":"Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia","volume":"43","author":"Ichimura","year":"2016","journal-title":"Auris Nasus Larynx"},{"issue":"4","key":"10.1016\/j.otc.2017.09.017_bib75","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00005537-200404000-00021","article-title":"Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia","volume":"114","author":"Jameson","year":"2004","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.otc.2017.09.017_bib76","first-page":"329","article-title":"Evaluation of hemostatic effects of Ankaferd as an alternative medicine","volume":"15","author":"Beyazit","year":"2010","journal-title":"Altern Med Rev"},{"issue":"1","key":"10.1016\/j.otc.2017.09.017_bib77","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/194589240602000116","article-title":"New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia","volume":"20","author":"Mahoney","year":"2006","journal-title":"Am J Rhinol"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666517301779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666517301779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T14:52:46Z","timestamp":1758466366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666517301779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0030666517301779"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2017.09.017","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hereditary Hemorrhagic Telangiectasia","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2017.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}